Literature DB >> 18520841

Pleomorphic adenoma with extensive myoepithelial component (myoepithelioma) of the lower eyelid.

Valentín Huerva1, M Carmen Sanchez, Ramón M Egido, Xavier Matías-Guiu.   

Abstract

A 58-year-old woman presented with a nodular lesion on the medial part of her left lower eyelid. The lesion had been removed 10 years ago, but showed subsequent recurrence with slow growth. The lesion was again partially removed at another institution prior to presentation. Afterward removal, the persistent lesion had rapid growth. On presentation to us, the lesion showed a clinical appearance that was very similar to a nodular basal cell carcinoma. A pentagonal full-thickness resection biopsy was performed. The pathologic study revealed clusters of tumor cells and some ductal proliferations. Immunohistochemistry demonstrated positive staining for p63, S-100, and smooth muscle actin. No atypia was observed. A diagnosis of pleomorphic adenoma with extensive myoepithelial component (myoepithelioma) was made. The authors conclude that myoepithelioma should be considered in the differential diagnosis of nodular recurrent masses in the eyelids of adults. Definitive diagnosis is possible only after surgical biopsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520841     DOI: 10.1097/IOP.0b013e318171a5ba

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

Review 1.  Myoepithelioma of the Orbital Apex and Middle Cranial Fossa: Case Report and Review of the Literature.

Authors:  Dustin M Hayward; David Yoo; John M Lee; Elizabeth Wild; Vikram C Prabhu
Journal:  Neuroophthalmology       Date:  2014-01-28

2.  Chondroid syringoma: a rare lid tumor.

Authors:  M Ashok Kumar; Krishnagopal Srikanth; Ramraj Vathsalya
Journal:  Indian J Ophthalmol       Date:  2013 Jan-Feb       Impact factor: 1.848

3.  Apocrine mixed tumor of the eyelid: a case report.

Authors:  Aileen Azari-Yam; Mohammad Abrishami
Journal:  Diagn Pathol       Date:  2016-03-24       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.